Defiance ETFs introduces RKLX and HIMZ, two 2X leveraged
single-stock ETFs designed to provide amplified exposure to Rocket
Lab USA, Inc. (NASDAQ: RKLB) and Hims & Hers Health Inc. (NYSE:
HIMS). These ETFs offer traders a way to seek enhanced returns on
Rocket Lab and Hims & Hers without requiring a margin account.
- RKLX, the Defiance Daily Target 2X Long RKLB ETF, seeks daily
investment results that correspond to twice (200%) the
daily percentage change of Rocket Lab, a company at the
forefront of satellite launches, space exploration, and
advanced aerospace systems.
- HIMZ, the Defiance Daily Target 2X Long HIMS ETF, seeks daily
investment results that correspond to twice (200%) the
daily return of Hims & Hers, a company pioneering
telehealth and direct-to-consumer healthcare
solutions.
“RKLX and HIMZ offer compelling opportunities for investors
seeking amplified exposure to Rocket Lab and Hims & Hers, two
companies driving innovation in their respective industries,” said
Sylvia Jablonski, CEO of Defiance ETFs. “With increasing demand for
satellite technology and digital healthcare solutions, Rocket Lab
and Hims & Hers continue to play key roles in shaping the
future of space exploration and telehealth.”
For more information, visit DefianceETFs.com
These Funds are not intended to be used by, and are not
appropriate for, investors who do not intend to actively monitor
and manage their portfolios. The Funds pursue a daily leveraged
investment objective, making them riskier than alternatives that do
not use leverage, as they magnify the performance of their
respective underlying securities. These Funds are not
suitable for all investors. They are designed for knowledgeable
investors who understand the potential consequences of seeking
daily leveraged (2X) investment results, recognize the risks
associated with the use of leverage, and are willing to frequently
monitor their portfolios. Over periods longer than a single day,
the Funds may lose value even if their underlying securities
increase in performance, and they will lose value if the underlying
securities remain flat. An investor could lose the full principal
value of their investment within a single day.
An investment in RKLX is not an investment in Rocket Lab USA,
Inc. An investment in HIMZ is not an investment in Hims & Hers
Health Inc.
About Defiance ETFs
Founded in 2018, Defiance is at the forefront of ETF innovation.
Defiance is a leading ETF issuer specializing in thematic, income,
and leveraged ETFs.
Our first-mover leveraged single-stock ETFs empower investors to
take amplified positions in high-growth companies, providing
precise leverage exposure without the need to open a margin
account.
IMPORTANT DISCLOSURES
Defiance ETFs LLC is the ETF sponsor. The Fund’s investment
adviser is Tidal Investments, LLC (“Tidal” or the “Adviser”).
The Funds’ investment objectives, risks, charges, and expenses
must be considered carefully before investing. The prospectus and
summary prospectus contain this and other important information
about the investment company. Please read carefully before
investing. A hard copy of the prospectuses can be requested by
calling 833.333.9383.
Investing involves risk. Principal loss is possible. As
an ETF, the funds’ may trade at a premium or discount to NAV.
Shares of any ETF are bought and sold at market price (not NAV) and
are not individually redeemed from the Fund. A portfolio
concentrated in a single industry or country, may be subject to a
higher degree of risk.
RKLB and HIMS Risks: The Fund invests in swap
contracts and options that are based on the share price of HIMS.
This subjects the Fund to certain of the same risks as if it owned
shares of HIMS even though it does not.
Indirect Investment Risk. RKLB and HIMS are not
affiliated with the Trust, the Fund, or the Adviser, or their
respective affiliates and are not involved with this offering in
any way and have no obligation to consider your Shares in taking
any corporate actions that might affect the value of Shares.
Trading Risk. The trading price of the fund may be subject to
volatility and could experience wide fluctuations due to various
factors. Short sellers may also play a significant role in trading
RKLB and HIMS potentially affecting the supply and demand dynamics
and contributing to market price volatility. Public perception and
external factors beyond the company’s control may influence RKLB’s
and HIMS’s stock price disproportionately.
Performance Risk. RKLB and HIMS may fail to meet publicly
announced guidelines or other expectations about its business,
which could cause the price of RKLB and HIMS to decline.
RKLB Aerospace & Defense Industry Risks. Companies in the
aerospace and defense industry are subject to risks stemming from
their reliance on government budgets and spending priorities, which
can fluctuate due to political and economic pressures. The
aerospace and defense industry is also affected by geopolitical
tensions, trade policies, and regulatory changes that can impact
market access and operational efficiency. Aerospace and defense
companies typically rely on complex supply chains for specialized
components and materials. Additionally, technological advancements
are critical for maintaining competitiveness in this sector, but
the high cost and uncertain outcomes of research and development
efforts may pose financial risks. Companies in this industry face
heightened cybersecurity risks due to the sensitive nature of their
technologies, and breaches can lead to operational disruptions,
reputational damage, and regulatory scrutiny.
RKLB Business Risks. RKLB has experienced rapid growth, with its
employee base and operations expanding substantially in recent
years, placing considerable demands on its management, operational
infrastructure, and financial resources. Continued growth is
dependent on RKLB’s ability to scale its revenue, improve
operational efficiencies, and maintain profitability while
effectively managing its increasingly complex organizational
structure. Additionally, interruptions from information technology
failures, cybersecurity breaches, or other infrastructure issues
could disrupt operations. RKLB’s ability to comply with applicable
regulations and adapt to changes in the industry also presents
ongoing risks.
HIMS Healthcare Providers & Services Industry Risks. The
healthcare providers and services industry can be significantly
affected by changing economic conditions, evolving patient
demographics, and fluctuations in demand for healthcare services.
Changes in healthcare regulations and policies, including those
related to insurance coverage and reimbursement, can materially
impact the industry. Additionally, the industry faces risks related
to litigation, operational disruptions, and evolving technologies
that may alter traditional service delivery models.
HIMS Business Risks. HIMS operates in highly competitive
markets, facing challenges from established healthcare providers,
retailers, pharmaceutical companies, and technology firms, which
may affect its competitive position. Additionally, the success of
HIMS is heavily reliant on its brand reputation, relationships with
healthcare providers and medical groups, and compliance with
complex healthcare and pharmacy regulations. Security breaches,
data loss, legal proceedings, or regulatory changes could harm its
operations and reputation.
RKLX and HIMZ Fund Risks
Leverage Risk. The Fund obtains investment
exposure in excess of its net assets by utilizing leverage and may
lose more money in market conditions that are adverse to its
investment objective than a fund that does not utilize leverage. An
investment in the Fund is exposed to the risk that a decline in the
daily performance of the Underlying Security will be magnified.
High Portfolio Turnover Risk. Daily rebalancing
of the Fund’s holdings pursuant to its daily investment objective
causes a much greater number of portfolio transactions when
compared to most ETFs.
Liquidity Risk. Some securities held by the
Fund may be difficult to sell or be illiquid, particularly during
times of market turmoil. Markets for securities or financial
instruments could be disrupted by a number of events, including,
but not limited to, an economic crisis, natural disasters,
epidemics/pandemics, new legislation or regulatory changes inside
or outside the United States.
Derivatives Risk. The Fund’s investments in
derivatives may pose risks in addition to, and greater than, those
associated with directly investing in securities or other ordinary
investments, including risk related to the market, leverage,
imperfect daily correlations with underlying investments or the
Fund’s other portfolio holdings, higher price volatility, lack of
availability, counterparty risk, liquidity, valuation and legal
restrictions.
Compounding and Market Volatility Risk. The
Fund has a daily leveraged investment objective and the Fund’s
performance for periods greater than a trading day will be the
result of each day’s returns compounded over the period, which is
very likely to differ from two times (200%) the Underlying
Security’s performance, before the Fund’s management fee and other
expenses.
Fixed Income Securities Risk. When the Fund
invests in fixed income securities, the value of your investment in
the Fund will fluctuate with changes in interest rates. Typically,
a rise in interest rates causes a decline in the value of fixed
income securities owned by the Fund.
Single Issuer Risk. Issuer-specific attributes
may cause an investment in the Fund to be more volatile than a
traditional pooled investment which diversifies risk of the market
generally. The value of the Fund, which focuses on an individual
security, may be more volatile than a traditional pooled investment
or the market as a whole and may perform differently from the value
of a traditional pooled investment or the market as a whole.
New Fund Risk. The Fund is a recently organized
management investment company with no operating history. As a
result, prospective investors do not have a track record or history
on which to base their investment decisions.
Diversification does not ensure a profit nor protect against
loss in a declining market.
Brokerage Commissions may be charged on trades.
Distributed by Foreside Fund Services, LLC
Contact Information
David Hanono
info@defianceetfs.com
833.333.9383
A photo accompanying this announcement is available
at: https://www.globenewswire.com/NewsRoom/AttachmentNg/25cf1c68-b060-42fa-b3cf-e1315eea5f0e
Hims and Hers Health (NYSE:HIMS)
Gráfico Histórico do Ativo
De Mar 2025 até Abr 2025
Hims and Hers Health (NYSE:HIMS)
Gráfico Histórico do Ativo
De Abr 2024 até Abr 2025